title: RETINAL RACEMOSE HEMANGIOMA WITH FOCAL MACULAR INVOLVEMENT.
abstract: OBJECTIVE
  To report a case of racemose hemangioma with macular involvement and treated with anti-vascular endothelial growth factor.
  
  
  METHODS
  Observational case report.
  
  
  RESULTS
  JFS, a 31-year-old woman, presented with a complaint of blurred vision in her right eye over the preceding 2 months, worsening during the previous month. An examination conducted in May 2013 showed visual acuity of 20/30 in her right eye and 20/20 in her left eye, deteriorating to 20/40 in the right eye 1 month later. Retinography of the right eye revealed a dilated tortuous retinal vessel in the lower temporal arcade, affecting the macular region. Because of progressive deterioration in the patient's visual acuity, she was treated with 3 intravitreal bevacizumab injections, with an interval of 1 month between them. At the end of the proposed treatment, the patient was followed up on an outpatient basis for 12 months, with visual acuity of 20/20 in both eyes and no signs of retinal exudation throughout the entire follow-up period.
  
  
  CONCLUSIONS
  Racemose hemangioma with focal macular involvement may lead to a progressive reduction in visual acuity because of exudation. Further studies need to be conducted to confirm the efficacy of bevacizumab injections to treat vascular malformation; however, this form of management does seem promising.
authors.affiliation: *Department of Opthalmology, University of the São Paulo Medical School-USP, São Paulo, Brazil; †Department of Ophthalmology, Jundiai College of Medicine, São Paulo, Brazil; and ‡Medical University Anhembi Morumbi, São Paulo, Brazil.
authors.forename: Alan K
authors.initials: AK
authors.lastname: Barreira
authors.forename: Aloisio F
authors.initials: AF
authors.lastname: Nakashima
authors.forename: Vitor K L
authors.initials: VK
authors.lastname: Takahashi
authors.forename: Geraldo A
authors.initials: GA
authors.lastname: Marques
authors.forename: Tomás
authors.initials: T
authors.lastname: Minelli
authors.forename: Artur M D
authors.initials: AM
authors.lastname: Santo
mesh_terms: D000328:Adult; D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D000068258:Bevacizumab / Q000627:therapeutic use*; D005260:Female; D006391:Hemangioma / Q000188:drug therapy*; D006801:Humans; D008269:Macular Edema / Q000188:drug therapy*; D019572:Retinal Neoplasms / Q000188:drug therapy*; D016896:Treatment Outcome
chemical_list: D020533:Angiogenesis Inhibitors; D000068258:Bevacizumab